Skip Navigation


European Heart Journal Advance Access originally published online on April 3, 2009
European Heart Journal 2009 30(9):1030-1032; doi:10.1093/eurheartj/ehp129
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/9/1030    most recent
ehp129v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Woo, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, K. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org

Perusal of risk stratification of acute myocardial infarction for half a century

Kam S. Woo*

Department of Biochemistry, The Chinese University of Hong Kong, Hong Kong SAR

* Corresponding author. Tel:/Fax: +852 2647 4966, Email: kamsangwoo@cuhk.edu.hk

This editorial refers to ‘Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction’{dagger}, by S.Q. Khan et al., on page 1057

The first 10% of the full text of this article appears below.

Acute coronary syndrome and acute myocardial infarction (AMI) in particular is a dangerous presentation of coronary artery disease (CAD). Myocardial infarction is the main cause of death in Western countries, with an in-hospital mortality of 6–13%. Overall mortality including death outside hospital has been estimated at 30–40%. After recovering from infarction, surviving patients remain vulnerable to cardiovascular events such as heart failure, recurrence of angina, reinfarction, arrhythmia, and sudden cardiac death. Treatment of AMI has advanced tremendously over the past 50 years, including establishment of coronary care units with defibrillation devices and haemodynamic . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
Sohail Q. Khan, Kelvin Ng, Onkar Dhillon, Dominic Kelly, Paulene Quinn, Iain B. Squire, Joan E. Davies, and Leong L. Ng
EHJ 2009 30: 1057-1065. [Abstract] [Full Text]